CardioRegen

Research area: Stem Cell Biology > Heart Regeneration | Status: Active

kids cycling

The Melbourne Centre for Cardiovascular Genomics and Regenerative Medicine (CardioRegen)

CardioRegen is a research centre focused on improving the lives of patients with childhood heart disease (CHD).

Our team of researchers and clinicians use genomics and stem cell medicine to understand the causes of CHD and for the discovery of new treatments.

CardioRegen is a research centre focused on improving the lives of patients with childhood heart disease (CHD).

Our team of researchers and clinicians use genomics and stem cell medicine to understand the causes of CHD and for the discovery of new...

CardioRegen is a research centre focused on improving the lives of patients with childhood heart disease (CHD).

Our team of researchers and clinicians use genomics and stem cell medicine to understand the causes of CHD and for the discovery of new treatments.

Overview

cardioregen logoThere has been an alarmingly rapid increase in the numbers and complexity of heart failure hospitalisations among children and adults living with CHD in recent time.

In Australia, most of these paediatric patients are cared for at the Royal Children's Hospital (RCH), which is the National Centre for Paediatric Heart Failure and Heart Transplantation.

As a team of clinicians and researchers working together on the Melbourne Children’s Campus, CardioRegen is uniquely positioned to capitalise on recent advances in regenerative medicine to deliver better outcomes for children with CHD.

Significantly, CardioRegen is a key program within the MCRI Heart Failure Flagship, underpinning several projects that bring together researchers and clinicians from across the Campus and Parkville Precinct.

CardioRegen provides enabling infrastructure, a vehicle for collaboration between clinicians and scientists across the Campus, as well as being the driving force for translation of stem cell medicine across the Heart Failure Flagship.

Our team have considerable strengths across the spectrum of CHD from discovery science through to clinical translation with international leaders in cardiac surgery, cardiology, and stem cell science. CardioRegen positions our campus as a global leader in stem cell medicine for childhood heart disease.

Since the inception of the centre in 2018, we have established key enabling infrastructures and a translational pipeline that drives all CardioRegen projects.

Cardio regen pipeline

CardioRegen pipeline: enabling infrastructure of the MCHTB via our strong links with the RCH, which includes the stem cell repository that drives much of what we achieved in our Diagnostics and Discovery pipeline. We are now positioned to expand this pipeline to include more drug screening, as well as translational programs of research that deliver regenerative medicine back to the clinic.

More resources

child in hospital

Tomorrow's cures need your donations today

Donate now